XOSPATA Tablets 40 mg

Astellas US LLC

Revision date : 2023-04-14

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Version

1.0

Revision date

2023-04-14

Product name

XOSPATA Tablets 40 mg

Product Synonyms

Gilteritinib

Chemical name

Proprietary

1.2.1 Relevant identified uses

Use of the Drug Product, ASP2215: Pharmaceutical research, manufacturing and clinical use. For professional use only

Icons in SDS

Company Information

company name

Astellas US LLC

Section 2

SECTION 2: Hazards identification

This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) It is in solid, final form for direct administration to the patient. Therefore, it is exempt from labeling, as defined in the 29 CFR 1910.1200(b)(5)(iii.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.